Orphan Drugs part 4: Fixing the System

This post was originally published on this site

Drug companies love the Orphan Drug Act. They say it encourages research into breakthrough therapies for people with rare disease. And sometimes that’s true. Lots of the time, though, the companies would’ve pursued the research anyhow. And those same companies have learned to game the Orphan Drug Act in a bunch of different ways, allowing them to jack up their prices for no good reason.

How could we fix the Orphan Drug Act? That’s the topic of this week’s Healthcare Triage.

Sources can be found in the posts Nick Bagley has written on the subject! Special thanks to him! http://theincidentaleconomist.com/wordpress/tag/orphan-drugs/

John Green — Executive Producer
Stan Muller — Director, Producer
Aaron Carroll — Writer
Mark Olsen – Graphics
Meredith Danko – Social Media

You can directly support Healthcare Triage on Patreon: http://vid.io/xqXr If you can afford to pay a little every month, it really helps us to continue producing great content.


Please enter your comment!
Please enter your name here